Kallelse till årsstämma i Promimic AB (publ)
Aktieägarna i Promimic AB (publ), org.nr 556657-7754, med säte i Mölndal, kallas härmed till årsstämma måndagen den 14 mars 2022 kl. 13.00, på AZ BioVenturesHub, HB4, c/o Astra Zeneca R&D…
Read moreNews
Press Release: HAnano Surface® Part of Novel Orthopaedic Oncology 510(k) Clearance
Promimic licensee, Onkos Surgical, receives FDA clearance of new addition to Limb Salvage System, marking the entry of HA<sup>nano</sup> Surface<sup>®</sup> into the large joint implant market with a system that…
Read morePress Release:First 3D printed HAnano Surface® modified implant gets FDA approval
Promimic AB (publ), the world’s leading innovator in nano surface modification, is pleased to announce the recent Innovasis, Inc. special 510(k) clearance from the U.S. Food and Drug Administration (FDA)…
Read morePress Release: First FDA approval for HAnano Surface® on a spinal implant
The first spinal device utilizing HAnano Surface to improve osseointegration has now been 510(k) approved by the FDA. Through partnership with Promimic, Cutting Edge Spine developed the EVOL SI Sacroiliac…
Read morePress Release: Promimic AB (publ) Announces Partnership with Onkos Surgical®
Promimic AB (publ) Announces Partnership with Onkos Surgical® for Development of Hydroxyapatite Surface Technology (HAnano Surface®) in Limb Salvage Surgery. Promimic AB (publ), the world’s leading innovator in nano surface…
Read moreDeveloping test methods for ultra-thin hydroxyapatite coatings
GOTHENBURG, NOVEMBER 02, 2018 Promimic will be present at the ASTM workshop on coatings for the Medical Device industry in Washington on the 6th of November. Per Kjellin, one of…
Read moreInnovation award goes to implant innovator
Per Kjellin earned a PhD in chemistry at Chalmers and now runs Promimic – a company which manufactures surface layers for implants. By developing an innovative surface layer for…
Read moreHAnano Surface® cleared for use on dental implants by FDA
GOTEHNBURG – December 14, 2017. Promimic announces that the Food and Drug Administration (FDA) has approved our HAnano Surface for use on dental implants in the USA with our partners…
Read morePromimic Expands Commercial Operations to the U.S.
Promimic is proud to announce that its new office, based in Austin, Texas, has opened. It is headed by the former CEO of Promimic Ulf Brogren, who will lead Promimic’s…
Read morePromimic Appoints New CEO and Starts Sales Operations in the U.S.
GOTHENBURG – January 17, 2017. Promimic today announces that the Board of Directors has appointed a new CEO, Mr. Magnus Larsson, who will start his assignment in January, 2017. Mr….
Read more